STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Raghvendra M. Srivastava(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh)
Cited by 77
Related Papers
Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy
|JNCI Journal of the National Cancer Institute|2008|79